Chris Rallis
Director/Board Member bei AEOLUS PHARMACEUTICALS, INC.
Vermögen: 509 719 $ am 31.03.2024
Profil
Chris A.
Rallis is an Independent Director at Fennec Pharmaceuticals, Inc., Aeolus Pharmaceuticals, Inc., and Salisbury School, Inc. He was previously the President & Chief Executive Officer at ImmunoBiosciences, Inc. and President, Chief Operating Officer & Director at Triangle Pharmaceuticals, Inc. He also served as a Director at Incara Pharmaceuticals Corp.
and as VP-Strategic Planning & Business Development at Burroughs Wellcome.
Rallis holds a graduate degree from Duke University and an undergraduate degree from Harvard College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2024 | 45 838 ( 0,17% ) | 509 719 $ | 31.03.2024 |
Aktive Positionen von Chris Rallis
| Unternehmen | Position | Beginn |
|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Director/Board Member | 01.06.2004 |
| FENNEC PHARMACEUTICALS INC. | Director/Board Member | 25.08.2011 |
| Salisbury School, Inc. | Director/Board Member | - |
Ehemalige bekannte Positionen von Chris Rallis
| Unternehmen | Position | Ende |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Director/Board Member | 10.06.2021 |
ImmunoBiosciences, Inc.
 ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Chief Executive Officer | 01.06.2007 |
| Incara Pharmaceuticals Corp. | Director/Board Member | 09.08.2004 |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | President | 01.01.2003 |
ImmunoBiosciences, Inc.
ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Chief Executive Officer | - |
Ausbildung von Chris Rallis
| Duke University | Graduate Degree |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TENAX THERAPEUTICS, INC. | Health Technology |
| FENNEC PHARMACEUTICALS INC. | Health Technology |
| AEOLUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
| Incara Pharmaceuticals Corp. | Health Technology |
ImmunoBiosciences, Inc.
ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Technology Services |
| Burroughs Wellcome | |
| Salisbury School, Inc. |
